drugset / Trial / NCT00712465

An Interaction Study With Digoxin and AZD1305

NCT00712465

Phase 1 Completed 18 enrolled AstraZeneca
RandomizedCrossoverOpen-labelTreatment

Summary

The primary purpose of this study is to learn more about how digoxin is handled by the body, i.e. absorption, distribution, metabolism and excretion, when administered alone and in combination with AZD1305. Secondary purposes are to learn more about how AZD1305 is handled by the body when administered alone and in combination with digoxin and to learn more about how AZD1305 and digoxin administered alone and in combination affect the body.

Timeline

Start
2008-08
Primary completion
2008-11
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD1305 Small molecule
Subject Digoxin Other / unclassified

Indications